Stanford set for drug trial boost
Sunday 28 September 1997
An independent safety board is meeting this weekend to tabulate the results of a "phase III," or final-stage clinical trial on several hundred patients in South Africa, where the infectious disease is prevalent, according to Robin Gilbert, analyst with Panmure Gordon.
The results are expected to reflect those of earlier trials in Vietnam, which showed the drug, SRL172, was more effective against the disease when used with common antibiotics made by Novartis, Hoechst and others, than on its own.
"If the Vietnamese trial results are reproduced over here, they could have themselves a blockbuster," said Erling Refsum, analyst at Yamaichi International (Europe). "We already know the drug works. This trial is more of a regulatory hoop they have to go through to get approval."
Stanford Rook shares have risen 19 per cent in the last five days, from a 52-week low of 445p to 531.5p in anticipation of the results.
The company, which is also developing the same "immunotherapy" drug as a treatment for various cancers and HIV, has said it plans to file for approval for the drug as a tuberculosis treatment in 1998.
Tuberculosis kills about 3 million people each year, mostly in developing regions such as Africa and Asia.
- 3 Daily Show's Jon Stewart destroys Fox News for its Ferguson coverage
Ashya King missing: Police hunt five-year-old boy with brain tumour snatched from Southampton hospital by his parents
YouTube video posted by Isis militants shows 'execution of 250 Syrian soldiers'
Daily Show's Jon Stewart destroys Fox News for its Ferguson coverage
Californian drought is so severe it's 'causing the ground to move'
Botched ice bucket challenge leaves man critically injured after plane drops hundreds of gallons of water
Exclusive: We share blame for creating 'jihad generation', says Muslim strategist
Robin Williams Emmys tribute led by Billy Crystal criticised for including 'racist' joke about Muslim woman
The Rotherham child abuse scandal is a tale of apologists, misogyny and double standards
Scottish independence TV debate: Pumped-up Alex Salmond bounces back in bruising second round against Alistair Darling
Do you realise just how foolish the UK looks?
Ukip Douglas Carswell defection: Tory MP jumps ship to join Nigel Farage
- < Previous
- Next >
iJobs Money & Business
£32000 - £38000 Per Annum Bonus, Life Insurance + Other Benefits: Clearwater P...
£400 - £500 per day: Orgtel: Test Manager - Banking - West Yorkshire - £400-£5...
£450 - £500 per day: Orgtel: SAS Developer, Chester, Banking, DI Studio, £450-...
£20000 - £30000 per annum + OTE £40 - £50K first year: SThree: SThree Group an...